Table 1. General and disease-related characteristics of the current study population (n=207)

Characteristics n (%) Characteristics n (%)
Gender (male) 134 (64.7) Previous IBD-related hospitalization 131 (63.3)
Age (yr), mean±SD 39.63+13.16 Previous IBD-related surgery 76 (36.7)
Age range (yr) Previous relapse 178 (86.0)
 ≤29 52 (25.1) Medications
 30-39 63 (30.4)  5-ASA 162 (78.3)
 40-49 46 (22.2)  Immunomodulators 128 (61.8)
 50-59 28 (13.5)  Biologics 94 (45.4)
 ≥60 18 (8.7)  Steroids 11 (5.3)
Married 113 (54.6) Route of medications
Living status  PO only 121 (58.5)
 With family member(s) 182 (87.9)  PO and parenteral 86 (41.5)
 Alone 22 (10.6) Number of medications
 With others 3 (1.5)  One 104 (50.2)
Education level  More than two 103 (49.8)
 ≤High school 48 (23.2) Number of pills (per day), mean±SD 6.21+3.97
 ≥Bachelor's degree 159 (76.8) Number of pills (per day)
Religion  <5 73 (35.3)
 Yes 88 (42.5)  ≥5 134 (64.7)
 No 119 (57.5) Number of doses (per day)
Occupation  Once 66 (31.9)
 Yes 140 (67.6)  Twice 66 (31.9)
 No 67 (32.4)  Three or more times 75 (36.2)
Monthly household income (Korean won) Outpatient visit interval (days), mean±SD 73.77+35.66
 <3 million 86 (41.5) Outpatient visit interval (days)
 ≥3 million 121 (58.5)  <28 31 (15.0)
Smoking  28-56 65 (31.4)
 Yes 28 (13.5)  57-84 40 (19.3)
 No 179 (86.5)  ≥85 71 (34.3)
Disease IBD education experience 170 (82.1)
 Crohn's disease 125 (60.4) Disease activity
 Ulcerative colitis 82 (39.6)  Remission 158 (76.3)
Disease duration (yr), mean±SD 10.09+6.33  Mild 34 (16.4)
Disease duration (yr)  Moderate 13 (6.3)
 <5 50 (24.2)  Severe 2 (1.0)
 5-9 52 (25.1)
 10-14 64 (30.9)
 ≥15 41 (19.8)
IBD, inflammatory bowel disease; 5-ASA, 5-aminosalicylic acid; PO, per oral.